

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 9.04027422 |
| 2 | central nervous system myelination (GO:0022010) | 9.04027422 |
| 3 | keratan sulfate catabolic process (GO:0042340) | 6.84928766 |
| 4 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 6.72531476 |
| 5 | glomerular basement membrane development (GO:0032836) | 6.04364417 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.88446074 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.88446074 |
| 8 | fatty acid elongation (GO:0030497) | 5.86223874 |
| 9 | metanephric mesenchyme development (GO:0072075) | 5.79547184 |
| 10 | kidney mesenchyme development (GO:0072074) | 5.48026915 |
| 11 | cell migration involved in heart development (GO:0060973) | 5.35122834 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.20807955 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 5.20807955 |
| 14 | collagen fibril organization (GO:0030199) | 4.91309856 |
| 15 | myelin maintenance (GO:0043217) | 4.77828731 |
| 16 | extracellular fibril organization (GO:0043206) | 4.76554932 |
| 17 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.63806433 |
| 18 | protein heterotrimerization (GO:0070208) | 4.61620436 |
| 19 | myelination (GO:0042552) | 4.49630030 |
| 20 | ensheathment of neurons (GO:0007272) | 4.47815579 |
| 21 | axon ensheathment (GO:0008366) | 4.47815579 |
| 22 | glomerular filtration (GO:0003094) | 4.36792783 |
| 23 | very long-chain fatty acid metabolic process (GO:0000038) | 4.17680206 |
| 24 | smooth muscle tissue development (GO:0048745) | 4.06054612 |
| 25 | fibril organization (GO:0097435) | 4.05557582 |
| 26 | aromatic amino acid family catabolic process (GO:0009074) | 4.04950880 |
| 27 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.00998169 |
| 28 | positive regulation of gastrulation (GO:2000543) | 4.00285824 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 3.95192957 |
| 30 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.87885151 |
| 31 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.81251272 |
| 32 | bone trabecula formation (GO:0060346) | 3.79534896 |
| 33 | heme transport (GO:0015886) | 3.76763242 |
| 34 | L-serine metabolic process (GO:0006563) | 3.76058802 |
| 35 | renal filtration (GO:0097205) | 3.75976090 |
| 36 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.67803861 |
| 37 | collagen metabolic process (GO:0032963) | 3.67270982 |
| 38 | collagen catabolic process (GO:0030574) | 3.65709331 |
| 39 | response to methylmercury (GO:0051597) | 3.64561729 |
| 40 | bile acid biosynthetic process (GO:0006699) | 3.63719439 |
| 41 | cell proliferation involved in metanephros development (GO:0072203) | 3.63257560 |
| 42 | dermatan sulfate biosynthetic process (GO:0030208) | 3.61019129 |
| 43 | regulation of lipoprotein metabolic process (GO:0050746) | 3.57917871 |
| 44 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.53147605 |
| 45 | creatine metabolic process (GO:0006600) | 3.52494899 |
| 46 | extracellular matrix assembly (GO:0085029) | 3.51777270 |
| 47 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.50690832 |
| 48 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.49983019 |
| 49 | cell differentiation involved in metanephros development (GO:0072202) | 3.46564086 |
| 50 | dermatan sulfate metabolic process (GO:0030205) | 3.44421073 |
| 51 | multicellular organismal catabolic process (GO:0044243) | 3.43187082 |
| 52 | negative regulation of protein localization to cell surface (GO:2000009) | 3.43051766 |
| 53 | negative regulation of cartilage development (GO:0061037) | 3.42174808 |
| 54 | keratan sulfate biosynthetic process (GO:0018146) | 3.39653356 |
| 55 | multicellular organismal metabolic process (GO:0044236) | 3.38891366 |
| 56 | oligodendrocyte differentiation (GO:0048709) | 3.35027067 |
| 57 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.32905962 |
| 58 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.30170054 |
| 59 | mesonephros development (GO:0001823) | 3.29708305 |
| 60 | cell proliferation involved in kidney development (GO:0072111) | 3.26166778 |
| 61 | positive regulation of odontogenesis (GO:0042482) | 3.26089695 |
| 62 | organ induction (GO:0001759) | 3.24598101 |
| 63 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.22952121 |
| 64 | acyl-CoA biosynthetic process (GO:0071616) | 3.22652975 |
| 65 | thioester biosynthetic process (GO:0035384) | 3.22652975 |
| 66 | sulfur amino acid catabolic process (GO:0000098) | 3.19083651 |
| 67 | cholesterol biosynthetic process (GO:0006695) | 3.18110252 |
| 68 | middle ear morphogenesis (GO:0042474) | 3.16999765 |
| 69 | glycerophospholipid catabolic process (GO:0046475) | 3.14500257 |
| 70 | import into cell (GO:0098657) | 3.13914172 |
| 71 | bile acid metabolic process (GO:0008206) | 3.13221211 |
| 72 | complement activation, alternative pathway (GO:0006957) | 3.12898948 |
| 73 | protein localization to cell surface (GO:0034394) | 3.12747362 |
| 74 | coenzyme catabolic process (GO:0009109) | 3.11583139 |
| 75 | extracellular matrix disassembly (GO:0022617) | 3.10942050 |
| 76 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.08095877 |
| 77 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.08095877 |
| 78 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.06797370 |
| 79 | glyoxylate metabolic process (GO:0046487) | 3.06245168 |
| 80 | iron coordination entity transport (GO:1901678) | 3.06122856 |
| 81 | tyrosine metabolic process (GO:0006570) | 3.05154107 |
| 82 | keratan sulfate metabolic process (GO:0042339) | 3.03475185 |
| 83 | L-amino acid import (GO:0043092) | 3.03164949 |
| 84 | mesenchyme morphogenesis (GO:0072132) | 3.02639215 |
| 85 | endocrine hormone secretion (GO:0060986) | 3.01762655 |
| 86 | aspartate family amino acid catabolic process (GO:0009068) | 3.00940847 |
| 87 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.99229415 |
| 88 | dicarboxylic acid catabolic process (GO:0043649) | 2.98221214 |
| 89 | regulation of cholesterol esterification (GO:0010872) | 2.96703134 |
| 90 | regulation of protein activation cascade (GO:2000257) | 2.94514709 |
| 91 | negative regulation of catenin import into nucleus (GO:0035414) | 2.94446602 |
| 92 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.86483531 |
| 93 | regulation of complement activation (GO:0030449) | 2.86369733 |
| 94 | plasma lipoprotein particle clearance (GO:0034381) | 2.85451299 |
| 95 | high-density lipoprotein particle remodeling (GO:0034375) | 2.83904809 |
| 96 | lung vasculature development (GO:0060426) | 2.83752867 |
| 97 | acyl-CoA metabolic process (GO:0006637) | 2.82208390 |
| 98 | thioester metabolic process (GO:0035383) | 2.82208390 |
| 99 | short-chain fatty acid metabolic process (GO:0046459) | 2.82172173 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 2.82132499 |
| 101 | regulation of triglyceride catabolic process (GO:0010896) | 2.81818432 |
| 102 | adhesion of symbiont to host cell (GO:0044650) | 2.81434926 |
| 103 | virion attachment to host cell (GO:0019062) | 2.81434926 |
| 104 | regulation of cholesterol metabolic process (GO:0090181) | 2.80805734 |
| 105 | mesenchymal cell differentiation (GO:0048762) | 2.80573684 |
| 106 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.80509986 |
| 107 | opsonization (GO:0008228) | 2.78806282 |
| 108 | response to dietary excess (GO:0002021) | 2.78701199 |
| 109 | cofactor catabolic process (GO:0051187) | 2.78451474 |
| 110 | head development (GO:0060322) | 2.78256466 |
| 111 | embryonic camera-type eye development (GO:0031076) | 2.77589433 |
| 112 | sterol biosynthetic process (GO:0016126) | 2.77371043 |
| 113 | tooth mineralization (GO:0034505) | 2.77315820 |
| 114 | response to lead ion (GO:0010288) | 2.77084724 |
| 115 | aromatic amino acid family metabolic process (GO:0009072) | 2.76722098 |
| 116 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.76166047 |
| 117 | homocysteine metabolic process (GO:0050667) | 2.75637597 |
| 118 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.75364202 |
| 119 | smooth muscle cell differentiation (GO:0051145) | 2.74664280 |
| 120 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.74335796 |
| 121 | type B pancreatic cell proliferation (GO:0044342) | 2.73601177 |
| 122 | axon extension involved in axon guidance (GO:0048846) | 2.72659796 |
| 123 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.72659796 |
| 124 | regulation of female gonad development (GO:2000194) | 2.72385561 |
| 125 | ethanol oxidation (GO:0006069) | 2.72349103 |
| 126 | regulation of organ formation (GO:0003156) | 2.71163637 |
| 127 | negative regulation of BMP signaling pathway (GO:0030514) | 2.70318652 |
| 128 | venous blood vessel morphogenesis (GO:0048845) | 2.70133724 |
| 129 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.69823620 |
| 130 | protein carboxylation (GO:0018214) | 2.69823620 |
| 131 | basement membrane organization (GO:0071711) | 2.69774389 |
| 132 | amyloid precursor protein metabolic process (GO:0042982) | 2.69078609 |
| 133 | apical protein localization (GO:0045176) | 2.68833947 |
| 134 | myelination in peripheral nervous system (GO:0022011) | 2.68536633 |
| 135 | peripheral nervous system axon ensheathment (GO:0032292) | 2.68536633 |
| 136 | non-canonical Wnt signaling pathway (GO:0035567) | 2.68535810 |
| 137 | reverse cholesterol transport (GO:0043691) | 2.68035008 |
| 138 | response to mercury ion (GO:0046689) | 2.67303016 |
| 139 | outflow tract septum morphogenesis (GO:0003148) | 2.67256292 |
| 140 | negative regulation of protein activation cascade (GO:2000258) | 2.67132107 |
| 141 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.65904081 |
| 142 | extracellular matrix organization (GO:0030198) | 2.65493391 |
| 143 | vasculature development (GO:0001944) | 2.65212041 |
| 144 | extracellular structure organization (GO:0043062) | 2.64590491 |
| 145 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.64437122 |
| 146 | lymph vessel development (GO:0001945) | 2.63804930 |
| 147 | cellular ketone body metabolic process (GO:0046950) | 2.62931410 |
| 148 | response to lipoprotein particle (GO:0055094) | 2.62574047 |
| 149 | alpha-amino acid catabolic process (GO:1901606) | 2.62422836 |
| 150 | amyloid precursor protein catabolic process (GO:0042987) | 2.58906353 |
| 151 | cholesterol efflux (GO:0033344) | 2.58763761 |
| 152 | establishment of mitochondrion localization (GO:0051654) | 2.58654066 |
| 153 | cellular amino acid catabolic process (GO:0009063) | 2.58522961 |
| 154 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.57987441 |
| 155 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.57987441 |
| 156 | acetyl-CoA metabolic process (GO:0006084) | 2.57863450 |
| 157 | asymmetric protein localization (GO:0008105) | 2.57069758 |
| 158 | endodermal cell differentiation (GO:0035987) | 2.56969359 |
| 159 | negative regulation of neurotransmitter transport (GO:0051589) | 2.56539375 |
| 160 | blood vessel maturation (GO:0001955) | 2.56384646 |
| 161 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.55609652 |
| 162 | peptide cross-linking (GO:0018149) | 2.54895818 |
| 163 | glycine transport (GO:0015816) | 2.54062319 |
| 164 | negative regulation of complement activation (GO:0045916) | 2.54010987 |
| 165 | low-density lipoprotein particle remodeling (GO:0034374) | 2.53459484 |
| 166 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.53385965 |
| 167 | mesenchymal cell proliferation (GO:0010463) | 2.52720896 |
| 168 | sulfur compound catabolic process (GO:0044273) | 2.52365422 |
| 169 | fibroblast migration (GO:0010761) | 2.52101735 |
| 170 | cellular response to cholesterol (GO:0071397) | 2.51251054 |
| 171 | endocardial cushion morphogenesis (GO:0003203) | 2.50783260 |
| 172 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.49469253 |
| 173 | response to redox state (GO:0051775) | 2.49427636 |
| 174 | neutral lipid biosynthetic process (GO:0046460) | 2.48428433 |
| 175 | acylglycerol biosynthetic process (GO:0046463) | 2.48428433 |
| 176 | regulation of collateral sprouting (GO:0048670) | 2.48313611 |
| 177 | negative regulation of embryonic development (GO:0045992) | 2.48108397 |
| 178 | cholesterol metabolic process (GO:0008203) | 2.48014446 |
| 179 | glycosaminoglycan catabolic process (GO:0006027) | 2.47732426 |
| 180 | triglyceride biosynthetic process (GO:0019432) | 2.47597767 |
| 181 | astrocyte development (GO:0014002) | 2.47586835 |
| 182 | endocardial cushion development (GO:0003197) | 2.46316717 |
| 183 | camera-type eye morphogenesis (GO:0048593) | 2.45964476 |
| 184 | regulation of plasminogen activation (GO:0010755) | 2.45835175 |
| 185 | extracellular regulation of signal transduction (GO:1900115) | 2.45443650 |
| 186 | extracellular negative regulation of signal transduction (GO:1900116) | 2.45443650 |
| 187 | paraxial mesoderm development (GO:0048339) | 2.41908043 |
| 188 | radial glial cell differentiation (GO:0060019) | 2.41281939 |
| 189 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.40715268 |
| 190 | chondroitin sulfate catabolic process (GO:0030207) | 2.39561956 |
| 191 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 2.38896374 |
| 192 | muscle tissue development (GO:0060537) | 2.37154730 |
| 193 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.35371578 |
| 194 | regulation of cartilage development (GO:0061035) | 2.35129950 |
| 195 | negative regulation of hormone metabolic process (GO:0032351) | 2.34867050 |
| 196 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.34699082 |
| 197 | tonic smooth muscle contraction (GO:0014820) | 2.34037551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.34491657 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.11108261 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79089227 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.79036368 |
| 5 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.38026847 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.37010875 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.32396555 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.10283873 |
| 9 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.09916237 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.07891354 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.06019097 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.05991664 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.04475225 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.92508867 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88378904 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80419105 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79750401 |
| 18 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79283054 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76812117 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.76640575 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.72116638 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.72116638 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70108191 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69771964 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68053766 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64970954 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.58890408 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.56409617 |
| 29 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.55727377 |
| 30 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.55727377 |
| 31 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.55491570 |
| 32 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.50631842 |
| 33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48894508 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47306404 |
| 35 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.45605499 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43776126 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41702811 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40225841 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.38665306 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.38002676 |
| 41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.37140466 |
| 42 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.36239002 |
| 43 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.36239002 |
| 44 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.36239002 |
| 45 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.35892899 |
| 46 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.35459346 |
| 47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32612970 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31760285 |
| 49 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.31219011 |
| 50 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31001700 |
| 51 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.29367817 |
| 52 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29106713 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27158478 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24214208 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23353120 |
| 56 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.21972940 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.21298477 |
| 58 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.20380412 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19739397 |
| 60 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17751636 |
| 61 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.15625305 |
| 62 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.14534017 |
| 63 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13907621 |
| 64 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13474252 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12958130 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12368685 |
| 67 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11639052 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09427676 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08944000 |
| 70 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.08279491 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07828813 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07496861 |
| 73 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.07412011 |
| 74 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.06251429 |
| 75 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.05950793 |
| 76 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.05772295 |
| 77 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05732234 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04699419 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04102799 |
| 80 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.04090995 |
| 81 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.03662016 |
| 82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.03485441 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02697573 |
| 84 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02270691 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02191023 |
| 86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00175484 |
| 87 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98307869 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97899853 |
| 89 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97598737 |
| 90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97321639 |
| 91 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.96634275 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95493235 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95262655 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94733578 |
| 95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94729827 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94420589 |
| 97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94210732 |
| 98 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.94178991 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93583199 |
| 100 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93389203 |
| 101 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93379805 |
| 102 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92723887 |
| 103 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92648280 |
| 104 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91880671 |
| 105 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91695582 |
| 106 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.91505271 |
| 107 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90906994 |
| 108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90829006 |
| 109 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 0.90827522 |
| 110 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90753276 |
| 111 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.90459697 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90386606 |
| 113 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.90306876 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90234115 |
| 115 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90234115 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90055141 |
| 117 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88729844 |
| 118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88522466 |
| 119 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.88354202 |
| 120 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.88228471 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87569114 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86710637 |
| 123 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86534644 |
| 124 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86475329 |
| 125 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.84534127 |
| 126 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84395593 |
| 127 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.83353191 |
| 128 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.82831187 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81708239 |
| 130 | STAT3_23295773_ChIP-Seq_U87_Human | 0.80287593 |
| 131 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79123459 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78041188 |
| 133 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.77854972 |
| 134 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.77854972 |
| 135 | KDM2B_26808549_Chip-Seq_REH_Human | 0.76732432 |
| 136 | TP53_16413492_ChIP-PET_HCT116_Human | 0.76364485 |
| 137 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.76236561 |
| 138 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75814092 |
| 139 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75542318 |
| 140 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.75454426 |
| 141 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74338575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.21184189 |
| 2 | MP0000920_abnormal_myelination | 3.83153612 |
| 3 | MP0005360_urolithiasis | 3.72472776 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.29787034 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.23438771 |
| 6 | MP0005257_abnormal_intraocular_pressure | 3.19019362 |
| 7 | MP0003690_abnormal_glial_cell | 3.16854445 |
| 8 | MP0009840_abnormal_foam_cell | 3.16767729 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 3.15343768 |
| 10 | MP0005365_abnormal_bile_salt | 3.09828157 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.93841710 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.82694574 |
| 13 | MP0003279_aneurysm | 2.79675072 |
| 14 | MP0003329_amyloid_beta_deposits | 2.52107619 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.42458380 |
| 16 | MP0005171_absent_coat_pigmentation | 2.37501915 |
| 17 | MP0001542_abnormal_bone_strength | 2.28945510 |
| 18 | MP0003878_abnormal_ear_physiology | 2.15109728 |
| 19 | MP0005377_hearing/vestibular/ear_phenot | 2.15109728 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.01604706 |
| 21 | MP0003011_delayed_dark_adaptation | 1.97784042 |
| 22 | MP0000566_synostosis | 1.95895469 |
| 23 | MP0003195_calcinosis | 1.95566254 |
| 24 | MP0005332_abnormal_amino_acid | 1.91126002 |
| 25 | MP0002102_abnormal_ear_morphology | 1.88680090 |
| 26 | MP0004885_abnormal_endolymph | 1.84401055 |
| 27 | MP0004043_abnormal_pH_regulation | 1.83875836 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.80998152 |
| 29 | MP0006054_spinal_hemorrhage | 1.80217140 |
| 30 | MP0005503_abnormal_tendon_morphology | 1.80170977 |
| 31 | MP0001661_extended_life_span | 1.76354645 |
| 32 | MP0000751_myopathy | 1.70941654 |
| 33 | MP0003634_abnormal_glial_cell | 1.68818036 |
| 34 | MP0000604_amyloidosis | 1.65674964 |
| 35 | MP0003136_yellow_coat_color | 1.62825447 |
| 36 | MP0009250_abnormal_appendicular_skeleto | 1.60507955 |
| 37 | MP0003880_abnormal_central_pattern | 1.58678375 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.58430650 |
| 39 | MP0000767_abnormal_smooth_muscle | 1.52068399 |
| 40 | MP0003252_abnormal_bile_duct | 1.49998077 |
| 41 | MP0004142_abnormal_muscle_tone | 1.49436976 |
| 42 | MP0005275_abnormal_skin_tensile | 1.48880547 |
| 43 | MP0004381_abnormal_hair_follicle | 1.48807805 |
| 44 | MP0001879_abnormal_lymphatic_vessel | 1.45794020 |
| 45 | MP0004270_analgesia | 1.44527688 |
| 46 | MP0001486_abnormal_startle_reflex | 1.41756942 |
| 47 | MP0002060_abnormal_skin_morphology | 1.35263775 |
| 48 | MP0002933_joint_inflammation | 1.35247669 |
| 49 | MP0005390_skeleton_phenotype | 1.35030192 |
| 50 | MP0001529_abnormal_vocalization | 1.32808715 |
| 51 | MP0003632_abnormal_nervous_system | 1.30236629 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.28764529 |
| 53 | MP0002272_abnormal_nervous_system | 1.27881408 |
| 54 | MP0000049_abnormal_middle_ear | 1.26910156 |
| 55 | MP0002295_abnormal_pulmonary_circulatio | 1.24434913 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.24227037 |
| 57 | MP0000013_abnormal_adipose_tissue | 1.21303232 |
| 58 | MP0003942_abnormal_urinary_system | 1.20989786 |
| 59 | MP0003633_abnormal_nervous_system | 1.17756830 |
| 60 | MP0003631_nervous_system_phenotype | 1.17035486 |
| 61 | MP0001905_abnormal_dopamine_level | 1.16638685 |
| 62 | MP0000163_abnormal_cartilage_morphology | 1.16333516 |
| 63 | MP0000383_abnormal_hair_follicle | 1.13200563 |
| 64 | MP0003385_abnormal_body_wall | 1.12671112 |
| 65 | MP0001346_abnormal_lacrimal_gland | 1.11288568 |
| 66 | MP0010678_abnormal_skin_adnexa | 1.10104815 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09287970 |
| 68 | MP0000534_abnormal_ureter_morphology | 1.07012458 |
| 69 | MP0000778_abnormal_nervous_system | 1.06079265 |
| 70 | MP0002229_neurodegeneration | 1.05523552 |
| 71 | MP0004742_abnormal_vestibular_system | 1.04787447 |
| 72 | MP0004019_abnormal_vitamin_homeostasis | 1.04336320 |
| 73 | MP0002932_abnormal_joint_morphology | 1.03923296 |
| 74 | MP0000462_abnormal_digestive_system | 1.03896598 |
| 75 | MP0004134_abnormal_chest_morphology | 1.03533771 |
| 76 | MP0002108_abnormal_muscle_morphology | 1.02637103 |
| 77 | MP0001243_abnormal_dermal_layer | 1.02284057 |
| 78 | MP0000647_abnormal_sebaceous_gland | 1.02196564 |
| 79 | MP0002896_abnormal_bone_mineralization | 1.01390817 |
| 80 | MP0002064_seizures | 1.00800562 |
| 81 | MP0003283_abnormal_digestive_organ | 1.00099280 |
| 82 | MP0000579_abnormal_nail_morphology | 0.99996823 |
| 83 | MP0000639_abnormal_adrenal_gland | 0.99994259 |
| 84 | MP0005369_muscle_phenotype | 0.99443866 |
| 85 | MP0005083_abnormal_biliary_tract | 0.99346588 |
| 86 | MP0002115_abnormal_skeleton_extremities | 0.99260994 |
| 87 | MP0001177_atelectasis | 0.98555458 |
| 88 | MP0005410_abnormal_fertilization | 0.97735433 |
| 89 | MP0005023_abnormal_wound_healing | 0.96072161 |
| 90 | MP0000733_abnormal_muscle_development | 0.95251766 |
| 91 | MP0008260_abnormal_autophagy | 0.93872179 |
| 92 | MP0003115_abnormal_respiratory_system | 0.91127456 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.91086869 |
| 94 | MP0003186_abnormal_redox_activity | 0.91037404 |
| 95 | MP0004272_abnormal_basement_membrane | 0.90023148 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 0.89432419 |
| 97 | MP0008569_lethality_at_weaning | 0.88826170 |
| 98 | MP0002127_abnormal_cardiovascular_syste | 0.88724855 |
| 99 | MP0000428_abnormal_craniofacial_morphol | 0.86608397 |
| 100 | MP0000003_abnormal_adipose_tissue | 0.86582118 |
| 101 | MP0002233_abnormal_nose_morphology | 0.86140970 |
| 102 | MP0005451_abnormal_body_composition | 0.85721358 |
| 103 | MP0005551_abnormal_eye_electrophysiolog | 0.85630813 |
| 104 | MP0003941_abnormal_skin_development | 0.84754031 |
| 105 | MP0001958_emphysema | 0.83809925 |
| 106 | MP0005197_abnormal_uvea_morphology | 0.82085862 |
| 107 | MP0005646_abnormal_pituitary_gland | 0.80940960 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.80465071 |
| 109 | MP0003075_altered_response_to | 0.79685753 |
| 110 | MP0003567_abnormal_fetal_cardiomyocyte | 0.78349309 |
| 111 | MP0001502_abnormal_circadian_rhythm | 0.77555964 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.77268437 |
| 113 | MP0002128_abnormal_blood_circulation | 0.76659744 |
| 114 | MP0002113_abnormal_skeleton_development | 0.76514347 |
| 115 | MP0002116_abnormal_craniofacial_bone | 0.76258238 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.76015955 |
| 117 | MP0009697_abnormal_copulation | 0.75319147 |
| 118 | MP0002133_abnormal_respiratory_system | 0.75016797 |
| 119 | MP0005388_respiratory_system_phenotype | 0.75016797 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.73296537 |
| 121 | MP0000609_abnormal_liver_physiology | 0.72975544 |
| 122 | MP0004084_abnormal_cardiac_muscle | 0.72888034 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.72220723 |
| 124 | MP0005647_abnormal_sex_gland | 0.71519647 |
| 125 | MP0005409_darkened_coat_color | 0.71478457 |
| 126 | MP0000747_muscle_weakness | 0.71181535 |
| 127 | MP0005670_abnormal_white_adipose | 0.71106416 |
| 128 | MP0002109_abnormal_limb_morphology | 0.71075093 |
| 129 | MP0000762_abnormal_tongue_morphology | 0.70968795 |
| 130 | MP0001614_abnormal_blood_vessel | 0.70118978 |
| 131 | MP0002249_abnormal_larynx_morphology | 0.70081412 |
| 132 | MP0000955_abnormal_spinal_cord | 0.69944978 |
| 133 | MP0001299_abnormal_eye_distance/ | 0.69913639 |
| 134 | MP0001756_abnormal_urination | 0.69743479 |
| 135 | MP0002090_abnormal_vision | 0.69015331 |
| 136 | MP0002282_abnormal_trachea_morphology | 0.68442814 |
| 137 | MP0003879_abnormal_hair_cell | 0.68075006 |
| 138 | MP0005645_abnormal_hypothalamus_physiol | 0.67651982 |
| 139 | MP0000749_muscle_degeneration | 0.67087698 |
| 140 | MP0008775_abnormal_heart_ventricle | 0.66413754 |
| 141 | MP0005508_abnormal_skeleton_morphology | 0.66057468 |
| 142 | MP0005595_abnormal_vascular_smooth | 0.65979207 |
| 143 | MP0008789_abnormal_olfactory_epithelium | 0.65966529 |
| 144 | MP0005193_abnormal_anterior_eye | 0.65342288 |
| 145 | MP0000759_abnormal_skeletal_muscle | 0.65245376 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.65128142 |
| 147 | MP0003755_abnormal_palate_morphology | 0.64782338 |
| 148 | MP0000613_abnormal_salivary_gland | 0.63904160 |
| 149 | MP0004147_increased_porphyrin_level | 0.63223216 |
| 150 | MP0005423_abnormal_somatic_nervous | 0.62614237 |
| 151 | MP0010368_abnormal_lymphatic_system | 0.62304378 |
| 152 | MP0005408_hypopigmentation | 0.62223561 |
| 153 | MP0002066_abnormal_motor_capabilities/c | 0.62101214 |
| 154 | MP0000467_abnormal_esophagus_morphology | 0.62042385 |
| 155 | MP0003935_abnormal_craniofacial_develop | 0.61799475 |
| 156 | MP0003868_abnormal_feces_composition | 0.61001549 |
| 157 | MP0005620_abnormal_muscle_contractility | 0.60999283 |
| 158 | MP0005195_abnormal_posterior_eye | 0.60843906 |
| 159 | MP0006138_congestive_heart_failure | 0.60573256 |
| 160 | MP0003091_abnormal_cell_migration | 0.60534664 |
| 161 | MP0003119_abnormal_digestive_system | 0.57176188 |
| 162 | MP0002114_abnormal_axial_skeleton | 0.56868460 |
| 163 | MP0001175_abnormal_lung_morphology | 0.56657516 |
| 164 | MP0001544_abnormal_cardiovascular_syste | 0.56295399 |
| 165 | MP0005385_cardiovascular_system_phenoty | 0.56295399 |
| 166 | MP0003938_abnormal_ear_development | 0.55451138 |
| 167 | MP0005164_abnormal_response_to | 0.54605077 |
| 168 | MP0005248_abnormal_Harderian_gland | 0.54131893 |
| 169 | MP0000026_abnormal_inner_ear | 0.53275769 |
| 170 | MP0000432_abnormal_head_morphology | 0.52847728 |
| 171 | MP0003718_maternal_effect | 0.52214920 |
| 172 | MP0010386_abnormal_urinary_bladder | 0.51462634 |
| 173 | MP0002135_abnormal_kidney_morphology | 0.50884362 |
| 174 | MP0005395_other_phenotype | 0.49168099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 6.42779406 |
| 2 | Neurofibrillary tangles (HP:0002185) | 6.09065358 |
| 3 | Aortic dissection (HP:0002647) | 5.81805141 |
| 4 | Aortic aneurysm (HP:0004942) | 5.31052714 |
| 5 | Soft skin (HP:0000977) | 5.13332103 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.88223873 |
| 7 | Vascular tortuosity (HP:0004948) | 4.85405509 |
| 8 | Bladder diverticulum (HP:0000015) | 4.66686537 |
| 9 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.63310771 |
| 10 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.63310771 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 4.44853519 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 4.38132728 |
| 13 | Arterial tortuosity (HP:0005116) | 4.05960315 |
| 14 | Xanthomatosis (HP:0000991) | 3.80832235 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.68539543 |
| 16 | Ankle contracture (HP:0006466) | 3.65588570 |
| 17 | Peritonitis (HP:0002586) | 3.61115303 |
| 18 | Shallow orbits (HP:0000586) | 3.56719272 |
| 19 | Dilatation of the ascending aorta (HP:0005111) | 3.54552009 |
| 20 | Abnormality of the corticospinal tract (HP:0002492) | 3.53051043 |
| 21 | Deep venous thrombosis (HP:0002625) | 3.49015920 |
| 22 | Fragile skin (HP:0001030) | 3.47337215 |
| 23 | Atrophic scars (HP:0001075) | 3.45762143 |
| 24 | Type 1 muscle fiber predominance (HP:0003803) | 3.41572887 |
| 25 | Striae distensae (HP:0001065) | 3.39633692 |
| 26 | Glomerulonephritis (HP:0000099) | 3.38239714 |
| 27 | Cerebral hypomyelination (HP:0006808) | 3.31664145 |
| 28 | Parakeratosis (HP:0001036) | 3.30884548 |
| 29 | Wrist flexion contracture (HP:0001239) | 3.24769558 |
| 30 | Increased corneal curvature (HP:0100692) | 3.20830982 |
| 31 | Keratoconus (HP:0000563) | 3.20830982 |
| 32 | Complement deficiency (HP:0004431) | 3.15063581 |
| 33 | Genu recurvatum (HP:0002816) | 3.12359996 |
| 34 | Prolonged partial thromboplastin time (HP:0003645) | 3.12175913 |
| 35 | Hyperextensible skin (HP:0000974) | 3.08994690 |
| 36 | Abnormal auditory evoked potentials (HP:0006958) | 3.04618396 |
| 37 | Onion bulb formation (HP:0003383) | 2.99511973 |
| 38 | Mitral valve prolapse (HP:0001634) | 2.99329908 |
| 39 | Distal arthrogryposis (HP:0005684) | 2.99142059 |
| 40 | Round ear (HP:0100830) | 2.97819345 |
| 41 | Nephritis (HP:0000123) | 2.96439514 |
| 42 | Peripheral hypomyelination (HP:0007182) | 2.96431297 |
| 43 | Cervical subluxation (HP:0003308) | 2.94826699 |
| 44 | Blue sclerae (HP:0000592) | 2.94618130 |
| 45 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.94285519 |
| 46 | Wormian bones (HP:0002645) | 2.92689410 |
| 47 | Alacrima (HP:0000522) | 2.92530621 |
| 48 | Amyloidosis (HP:0011034) | 2.85779088 |
| 49 | Broad metatarsal (HP:0001783) | 2.85242533 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 2.82613396 |
| 51 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.80376432 |
| 52 | Abnormality of glycine metabolism (HP:0010895) | 2.80376432 |
| 53 | Axonal loss (HP:0003447) | 2.80091031 |
| 54 | Pulmonary artery stenosis (HP:0004415) | 2.77723207 |
| 55 | Bowel diverticulosis (HP:0005222) | 2.77113590 |
| 56 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.77009421 |
| 57 | Aplasia of the phalanges of the hand (HP:0009802) | 2.77009421 |
| 58 | Aplasia involving bones of the extremities (HP:0009825) | 2.77009421 |
| 59 | Follicular hyperkeratosis (HP:0007502) | 2.75583932 |
| 60 | Supranuclear gaze palsy (HP:0000605) | 2.75464534 |
| 61 | Premature skin wrinkling (HP:0100678) | 2.74308214 |
| 62 | Vertebral compression fractures (HP:0002953) | 2.70199346 |
| 63 | Coronal craniosynostosis (HP:0004440) | 2.67482270 |
| 64 | Neonatal short-limb short stature (HP:0008921) | 2.66758526 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.66314195 |
| 66 | Abnormality of dentin (HP:0010299) | 2.59912618 |
| 67 | Intention tremor (HP:0002080) | 2.58371519 |
| 68 | Wide anterior fontanel (HP:0000260) | 2.57744536 |
| 69 | Epidermoid cyst (HP:0200040) | 2.54638345 |
| 70 | Biconcave vertebral bodies (HP:0004586) | 2.54090190 |
| 71 | Osteoarthritis (HP:0002758) | 2.53731525 |
| 72 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.51871257 |
| 73 | Joint laxity (HP:0001388) | 2.51346939 |
| 74 | Cerebral aneurysm (HP:0004944) | 2.50776422 |
| 75 | Hypophosphatemic rickets (HP:0004912) | 2.50688186 |
| 76 | Turricephaly (HP:0000262) | 2.47450317 |
| 77 | Limited hip movement (HP:0008800) | 2.46770187 |
| 78 | Vascular calcification (HP:0004934) | 2.46366435 |
| 79 | Scanning speech (HP:0002168) | 2.44663456 |
| 80 | Methylmalonic acidemia (HP:0002912) | 2.44068938 |
| 81 | Abnormality of the anterior chamber (HP:0000593) | 2.43788376 |
| 82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.41969661 |
| 83 | Aplasia of the musculature (HP:0100854) | 2.41869239 |
| 84 | Aortic valve stenosis (HP:0001650) | 2.41238959 |
| 85 | Cardiovascular calcification (HP:0011915) | 2.41065250 |
| 86 | Overgrowth (HP:0001548) | 2.41014675 |
| 87 | Spondylolisthesis (HP:0003302) | 2.40562109 |
| 88 | Megalencephaly (HP:0001355) | 2.39485752 |
| 89 | Spastic paraparesis (HP:0002313) | 2.39380942 |
| 90 | Spinal rigidity (HP:0003306) | 2.39048498 |
| 91 | Osteolytic defects of the hand bones (HP:0009699) | 2.38891747 |
| 92 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.38891747 |
| 93 | Joint stiffness (HP:0001387) | 2.38358698 |
| 94 | Synostosis involving the elbow (HP:0003938) | 2.37763992 |
| 95 | Humeroradial synostosis (HP:0003041) | 2.37763992 |
| 96 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.37251973 |
| 97 | Cerebral hemorrhage (HP:0001342) | 2.36140574 |
| 98 | Calcaneovalgus deformity (HP:0001848) | 2.35883595 |
| 99 | Hip contracture (HP:0003273) | 2.33758296 |
| 100 | Hypobetalipoproteinemia (HP:0003563) | 2.31916603 |
| 101 | Absent phalangeal crease (HP:0006109) | 2.30727518 |
| 102 | Deformed tarsal bones (HP:0008119) | 2.29486800 |
| 103 | Hypoalphalipoproteinemia (HP:0003233) | 2.29447828 |
| 104 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.28882279 |
| 105 | Ectopia lentis (HP:0001083) | 2.28393500 |
| 106 | Aneurysm (HP:0002617) | 2.28103180 |
| 107 | Termporal pattern (HP:0011008) | 2.27393743 |
| 108 | Insidious onset (HP:0003587) | 2.27393743 |
| 109 | Abnormal delivery (HP:0001787) | 2.27014836 |
| 110 | Narrow nasal bridge (HP:0000446) | 2.26549543 |
| 111 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.23860112 |
| 112 | Hyperammonemia (HP:0001987) | 2.22468282 |
| 113 | Ketosis (HP:0001946) | 2.22170029 |
| 114 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.21291041 |
| 115 | Leukodystrophy (HP:0002415) | 2.20899672 |
| 116 | Decreased lacrimation (HP:0000633) | 2.18792229 |
| 117 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.18334530 |
| 118 | Clumsiness (HP:0002312) | 2.15090405 |
| 119 | CNS hypomyelination (HP:0003429) | 2.14851794 |
| 120 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.14661113 |
| 121 | Hypolipoproteinemia (HP:0010981) | 2.14585415 |
| 122 | Venous insufficiency (HP:0005293) | 2.14479312 |
| 123 | Spastic gait (HP:0002064) | 2.13949850 |
| 124 | Fat malabsorption (HP:0002630) | 2.12074118 |
| 125 | Premature rupture of membranes (HP:0001788) | 2.12027485 |
| 126 | Sensory axonal neuropathy (HP:0003390) | 2.11910899 |
| 127 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.11857140 |
| 128 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11118358 |
| 129 | Infantile muscular hypotonia (HP:0008947) | 2.10835036 |
| 130 | Peripheral demyelination (HP:0011096) | 2.07867438 |
| 131 | Corneal dystrophy (HP:0001131) | 2.06889336 |
| 132 | Mitral stenosis (HP:0001718) | 2.06031412 |
| 133 | Anterior segment dysgenesis (HP:0007700) | 2.05477155 |
| 134 | Paraparesis (HP:0002385) | 2.05285501 |
| 135 | Ulnar deviation of the wrist (HP:0003049) | 2.05227440 |
| 136 | Thickened helices (HP:0000391) | 2.04418959 |
| 137 | Slender build (HP:0001533) | 2.03479609 |
| 138 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02012788 |
| 139 | Prolonged neonatal jaundice (HP:0006579) | 2.00791148 |
| 140 | Aortic regurgitation (HP:0001659) | 2.00401027 |
| 141 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.00285542 |
| 142 | Hyperglycinemia (HP:0002154) | 1.98719916 |
| 143 | Anteriorly placed anus (HP:0001545) | 1.96910122 |
| 144 | Emphysema (HP:0002097) | 1.96606060 |
| 145 | Torticollis (HP:0000473) | 1.95431017 |
| 146 | Hyperglycinuria (HP:0003108) | 1.95163325 |
| 147 | Partial duplication of the phalanx of hand (HP:0009999) | 1.94626515 |
| 148 | White forelock (HP:0002211) | 1.94594635 |
| 149 | Mild short stature (HP:0003502) | 1.93089087 |
| 150 | Venous abnormality (HP:0002624) | 1.92981739 |
| 151 | Steatorrhea (HP:0002570) | 1.92768650 |
| 152 | Thin bony cortex (HP:0002753) | 1.91851186 |
| 153 | Abnormality of complement system (HP:0005339) | 1.91464061 |
| 154 | Hypoglycemic coma (HP:0001325) | 1.90931876 |
| 155 | Hypoplasia of the iris (HP:0007676) | 1.90779597 |
| 156 | Camptodactyly of toe (HP:0001836) | 1.90756305 |
| 157 | Joint hemorrhage (HP:0005261) | 1.90435648 |
| 158 | Hepatosplenomegaly (HP:0001433) | 1.89334180 |
| 159 | Patchy hypopigmentation of hair (HP:0011365) | 1.88078420 |
| 160 | Recurrent corneal erosions (HP:0000495) | 1.88067988 |
| 161 | Muscle fiber splitting (HP:0003555) | 1.86932768 |
| 162 | Delayed CNS myelination (HP:0002188) | 1.86604454 |
| 163 | Cholecystitis (HP:0001082) | 1.86274020 |
| 164 | Abnormal gallbladder physiology (HP:0012438) | 1.86274020 |
| 165 | Abnormal finger flexion creases (HP:0006143) | 1.86061091 |
| 166 | Spastic tetraparesis (HP:0001285) | 1.85810168 |
| 167 | Broad ribs (HP:0000885) | 1.85327506 |
| 168 | Myokymia (HP:0002411) | 1.85205200 |
| 169 | Conjugated hyperbilirubinemia (HP:0002908) | 1.85131471 |
| 170 | Confusion (HP:0001289) | 1.85118768 |
| 171 | Breech presentation (HP:0001623) | 1.84541835 |
| 172 | Abnormal gallbladder morphology (HP:0012437) | 1.84480202 |
| 173 | Dysmetria (HP:0001310) | 1.83493444 |
| 174 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.81292595 |
| 175 | Choreoathetosis (HP:0001266) | 1.81287619 |
| 176 | Deviation of the hallux (HP:0010051) | 1.76560681 |
| 177 | Hallux valgus (HP:0001822) | 1.75844165 |
| 178 | Delayed cranial suture closure (HP:0000270) | 1.75574759 |
| 179 | Ovoid vertebral bodies (HP:0003300) | 1.74465879 |
| 180 | Flat cornea (HP:0007720) | 1.72697564 |
| 181 | Inguinal hernia (HP:0000023) | 1.71385551 |
| 182 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71270861 |
| 183 | Thin skin (HP:0000963) | 1.68797237 |
| 184 | Broad toe (HP:0001837) | 1.67753268 |
| 185 | Gingival overgrowth (HP:0000212) | 1.66921637 |
| 186 | Preaxial foot polydactyly (HP:0001841) | 1.66818075 |
| 187 | Abnormality of the acetabulum (HP:0003170) | 1.64654453 |
| 188 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.63970162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.16763877 |
| 2 | MYLK | 3.97689100 |
| 3 | FGFR2 | 3.87203281 |
| 4 | TGFBR2 | 3.64671455 |
| 5 | OXSR1 | 3.52578461 |
| 6 | PDGFRA | 3.19446929 |
| 7 | LATS1 | 3.17352355 |
| 8 | PKN1 | 3.06561849 |
| 9 | EPHB1 | 2.89470293 |
| 10 | BCKDK | 2.38887840 |
| 11 | MET | 2.32529888 |
| 12 | RIPK1 | 2.28307938 |
| 13 | INSRR | 2.08480403 |
| 14 | EPHB2 | 2.06006811 |
| 15 | MAPKAPK5 | 2.01627684 |
| 16 | KIT | 1.95631799 |
| 17 | SIK1 | 1.94893570 |
| 18 | NEK9 | 1.93527692 |
| 19 | PBK | 1.91953265 |
| 20 | GRK5 | 1.91779133 |
| 21 | MOS | 1.90614352 |
| 22 | BCR | 1.86871167 |
| 23 | WNK4 | 1.86169737 |
| 24 | LIMK1 | 1.84815319 |
| 25 | CSNK1A1L | 1.77258826 |
| 26 | STK38L | 1.73849974 |
| 27 | SGK223 | 1.70927045 |
| 28 | SGK494 | 1.70927045 |
| 29 | CSNK1G3 | 1.70205182 |
| 30 | MAPKAPK3 | 1.69019385 |
| 31 | TGFBR1 | 1.67576886 |
| 32 | NEK6 | 1.63686459 |
| 33 | CAMK2B | 1.57023091 |
| 34 | PHKG2 | 1.55534809 |
| 35 | PHKG1 | 1.55534809 |
| 36 | NTRK1 | 1.53321748 |
| 37 | PAK2 | 1.52800622 |
| 38 | STK3 | 1.50227403 |
| 39 | NLK | 1.49604223 |
| 40 | CSNK1G1 | 1.49567140 |
| 41 | PRPF4B | 1.48765704 |
| 42 | WNK1 | 1.47477863 |
| 43 | DMPK | 1.41800574 |
| 44 | GRK1 | 1.41771117 |
| 45 | ROCK2 | 1.41681732 |
| 46 | ADRBK1 | 1.38111682 |
| 47 | CASK | 1.37670795 |
| 48 | LATS2 | 1.34925389 |
| 49 | CSNK1G2 | 1.33645743 |
| 50 | PIK3CG | 1.32631417 |
| 51 | UHMK1 | 1.30409589 |
| 52 | AKT3 | 1.28962415 |
| 53 | CAMK2D | 1.27903139 |
| 54 | CAMK2G | 1.27672473 |
| 55 | PRKD3 | 1.25130443 |
| 56 | PAK6 | 1.23680863 |
| 57 | FRK | 1.23213203 |
| 58 | EPHA4 | 1.20790320 |
| 59 | ERN1 | 1.20627742 |
| 60 | ADRBK2 | 1.19842887 |
| 61 | MST4 | 1.18409490 |
| 62 | GRK7 | 1.15525527 |
| 63 | PRKCH | 1.10263730 |
| 64 | PINK1 | 1.09835728 |
| 65 | CDC42BPA | 1.08093969 |
| 66 | STK38 | 1.07861660 |
| 67 | MAP3K6 | 1.05890137 |
| 68 | PDGFRB | 1.05711627 |
| 69 | PRKD1 | 1.02349511 |
| 70 | CAMK1G | 1.00812977 |
| 71 | EPHA3 | 1.00801978 |
| 72 | FGR | 0.99664065 |
| 73 | BMPR1B | 0.99342873 |
| 74 | ERBB4 | 0.98604606 |
| 75 | DYRK2 | 0.97378186 |
| 76 | CDK19 | 0.96666437 |
| 77 | NTRK2 | 0.96237787 |
| 78 | CAMK1D | 0.94434485 |
| 79 | PTK2 | 0.94129650 |
| 80 | MAP2K2 | 0.92732299 |
| 81 | LMTK2 | 0.90578816 |
| 82 | FER | 0.90282620 |
| 83 | TESK2 | 0.90274786 |
| 84 | NME1 | 0.89898351 |
| 85 | MAP2K1 | 0.89818079 |
| 86 | ACVR1B | 0.89703551 |
| 87 | PDK2 | 0.89696808 |
| 88 | STK24 | 0.89515023 |
| 89 | ABL2 | 0.89003316 |
| 90 | CAMK2A | 0.88663156 |
| 91 | CLK1 | 0.88276130 |
| 92 | PRKCQ | 0.86922415 |
| 93 | TRIB3 | 0.86005246 |
| 94 | GSK3A | 0.85492270 |
| 95 | MARK2 | 0.84893521 |
| 96 | EEF2K | 0.82453542 |
| 97 | ARAF | 0.81306875 |
| 98 | PRKCE | 0.75883833 |
| 99 | ROCK1 | 0.72311994 |
| 100 | DDR2 | 0.72135634 |
| 101 | TRPM7 | 0.71650624 |
| 102 | MAP3K13 | 0.70776756 |
| 103 | PIK3CA | 0.70330824 |
| 104 | MAP3K7 | 0.67826350 |
| 105 | MUSK | 0.67213565 |
| 106 | TIE1 | 0.66675335 |
| 107 | IRAK2 | 0.65699910 |
| 108 | PAK3 | 0.65597026 |
| 109 | MAPK12 | 0.64832419 |
| 110 | TESK1 | 0.64741460 |
| 111 | PRKD2 | 0.64202425 |
| 112 | CDK5 | 0.63702660 |
| 113 | MAPK15 | 0.63668951 |
| 114 | PDPK1 | 0.61787092 |
| 115 | PRKG1 | 0.61604359 |
| 116 | RPS6KA2 | 0.60501205 |
| 117 | ERBB3 | 0.60117084 |
| 118 | MARK1 | 0.59857587 |
| 119 | RET | 0.58179258 |
| 120 | MAPK7 | 0.57770039 |
| 121 | FGFR4 | 0.56436514 |
| 122 | MAPK4 | 0.55623643 |
| 123 | MST1R | 0.54624394 |
| 124 | TYK2 | 0.53381199 |
| 125 | ICK | 0.52483727 |
| 126 | BMX | 0.52410770 |
| 127 | PRKACB | 0.50388496 |
| 128 | PTK2B | 0.50078494 |
| 129 | CAMK1 | 0.49164995 |
| 130 | FGFR3 | 0.48591439 |
| 131 | CSNK1A1 | 0.48583217 |
| 132 | NTRK3 | 0.48395484 |
| 133 | FLT3 | 0.48057085 |
| 134 | FYN | 0.48055550 |
| 135 | CSNK1D | 0.47807062 |
| 136 | TNIK | 0.47599596 |
| 137 | TYRO3 | 0.47010351 |
| 138 | FGFR1 | 0.46334421 |
| 139 | RPS6KA6 | 0.46260317 |
| 140 | RPS6KC1 | 0.45881328 |
| 141 | RPS6KL1 | 0.45881328 |
| 142 | DAPK3 | 0.45819012 |
| 143 | MAPK1 | 0.45619660 |
| 144 | DAPK2 | 0.45216751 |
| 145 | PRKAA2 | 0.44596477 |
| 146 | CDK14 | 0.43623443 |
| 147 | MTOR | 0.42558647 |
| 148 | PRKACA | 0.41796316 |
| 149 | CDK15 | 0.41273630 |
| 150 | MELK | 0.40964212 |
| 151 | TTN | 0.40033773 |
| 152 | ILK | 0.39264416 |
| 153 | PRKCZ | 0.38374425 |
| 154 | PNCK | 0.38035913 |
| 155 | MAPK13 | 0.34927070 |
| 156 | CDK18 | 0.34867220 |
| 157 | CSK | 0.33817495 |
| 158 | PRKACG | 0.33285876 |
| 159 | INSR | 0.32086628 |
| 160 | PTK6 | 0.29628478 |
| 161 | OBSCN | 0.28971524 |
| 162 | CDK11A | 0.28908970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.16010492 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.56307959 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.40722295 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.14055099 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.64910417 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.63385486 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.41293902 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.40106522 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29304912 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 2.28126066 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.26194049 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.25558206 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.22771176 |
| 14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.20547801 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19530720 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.15926714 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01491702 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97163668 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.93737458 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.87247382 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.85860167 |
| 22 | Amoebiasis_Homo sapiens_hsa05146 | 1.83214964 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.82888854 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.79398247 |
| 25 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.78433893 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74362890 |
| 27 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.73692407 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.71204372 |
| 29 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.70223616 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.68067325 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63391851 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62217668 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60537282 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58697228 |
| 35 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.55110413 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53254721 |
| 37 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.49806342 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49726645 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.43654277 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.43630580 |
| 41 | Circadian rhythm_Homo sapiens_hsa04710 | 1.40816943 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.37948631 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.37662347 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.36453651 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 1.33078605 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.32347833 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32123033 |
| 48 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.30596542 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25822602 |
| 50 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.24581625 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.22733098 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.20245606 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18392011 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16633105 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.14889249 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11328603 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09961589 |
| 58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.09776365 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09619602 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 1.06684347 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05351821 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04373215 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04226516 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.03250203 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99745164 |
| 66 | Melanoma_Homo sapiens_hsa05218 | 0.98488599 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98287041 |
| 68 | Pathways in cancer_Homo sapiens_hsa05200 | 0.95589733 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94443625 |
| 70 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.92431961 |
| 71 | Melanogenesis_Homo sapiens_hsa04916 | 0.91890413 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89249360 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87907331 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87867617 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87452069 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.87219137 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.84723952 |
| 78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.84356709 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82347233 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78896917 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.78865643 |
| 82 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.76043917 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75926061 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75287789 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75141202 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75092673 |
| 87 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.70580304 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.68112626 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67583975 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66628448 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64876926 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64083128 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63880068 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61122223 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60767670 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56926679 |
| 97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56144004 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55269557 |
| 99 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55084973 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.52500446 |
| 101 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52097726 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.50876177 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50690277 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50274112 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50262655 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.49219521 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48811787 |
| 108 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47720087 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47465412 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.46998103 |
| 111 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46988708 |
| 112 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46785193 |
| 113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45671976 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43520920 |
| 115 | Taste transduction_Homo sapiens_hsa04742 | 0.42152260 |
| 116 | Protein export_Homo sapiens_hsa03060 | 0.39163229 |
| 117 | Long-term depression_Homo sapiens_hsa04730 | 0.39069954 |
| 118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37129484 |
| 119 | Lysosome_Homo sapiens_hsa04142 | 0.36636745 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36565197 |
| 121 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34057981 |
| 122 | Circadian entrainment_Homo sapiens_hsa04713 | 0.33150743 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.32993048 |
| 124 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.32919513 |
| 125 | Adherens junction_Homo sapiens_hsa04520 | 0.30718458 |
| 126 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30586255 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.28019680 |
| 128 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.23599340 |
| 129 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21609502 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.19102297 |
| 131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.18785265 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.18523888 |
| 133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.18272857 |
| 134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17495276 |
| 135 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17038321 |
| 136 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.15114247 |
| 137 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.14817909 |
| 138 | Malaria_Homo sapiens_hsa05144 | 0.14782162 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.14308761 |
| 140 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.13919552 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.13891375 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13843897 |
| 143 | Morphine addiction_Homo sapiens_hsa05032 | 0.13063629 |
| 144 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.13053112 |
| 145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10076873 |
| 146 | Parkinsons disease_Homo sapiens_hsa05012 | 0.08247243 |
| 147 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.07785974 |

